slides · global inventory
Problem Agitate Solution
Arc collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 26,550
Current window 21,901-21,930
Pages 885
Rows per page 30
Arc
21,901-21,930 of 26,550
17
Kaplan-Meier survival analysis showing statistically significant improvement in PFS for matched treatments.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations Beat · Evidence & Proof1 hit
18
The slide uses a horizontal process-like layout to showcase four distinct pillars of their R&D engine.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations Beat · Evidence & Proof1 hit
30
MTD = Maximum Tolerated Dose; ORR = Objective Response Rate; ABS = Adenosine Burden Score.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations Beat · Visualization1 hit
31
The slide uses a human anatomy diagram to map patient counts to specific disease locations.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations Beat · Visualization1 hit
03
The slide uses a circular central graphic to anchor the list of pain points.Hyperfine | Investor Presentation Deck | 16 slides · Hyperfine
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
04
Hyperfine | Investor Presentation Deck | 16 slidesHyperfine | Investor Presentation Deck | 16 slides · Hyperfine
Pitch deck Investor relations Beat · Market SizingLoop · Cost Of Inaction1 hit
05
The slide uses a hub-and-spoke layout to surround the product image with key value propositions.Hyperfine | Investor Presentation Deck | 16 slides · Hyperfine
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
06
Hyperfine | Investor Presentation Deck | 16 slidesHyperfine | Investor Presentation Deck | 16 slides · Hyperfine
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
10
The slide uses a hub-and-spoke diagram to show the decomposition of the total market.Hyperfine | Investor Presentation Deck | 16 slides · Hyperfine
Pitch deck Investor relations Beat · Market Opportunity1 hit
14
Includes a disclaimer about 2023 figures representing guidance midpoints.Hyperfine | Investor Presentation Deck | 16 slides · Hyperfine
Pitch deck Investor relations Beat · Financial ProfileLoop · Quick Win Big Bet1 hit
03
The slide highlights two distinct pipelines: TSTx (Tissue Specific Therapeutics) and NextGen CAR-T.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations Beat · Problem (Identify pain)1 hit
04
The slide uses a wave-like visual to represent market segments and their associated financial opportunities.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
05
The table uses a standard pharmaceutical pipeline format, categorizing by clinical vs preclinical status and therapy type (CAR-T vs TSTx).Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
06
The slide uses a grouped bar chart to compare clinical outcomes across different patient segments (No BCMA, Yes BCMA, Overall).Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
07
Includes detailed source citations in the footer.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
08
Includes detailed source citations in the footer.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
09
The slide uses a two-column layout to separate milestones by drug candidate.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
10
The slide uses a side-by-side comparison of two proprietary technology platforms.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
11
Immix Biopharma | Investor Presentation Deck | 46 slidesImmix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
12
The slide uses a matrix structure to compare clinical outcomes against three key value propositions.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
13
Includes comparative bar charts and flow cytometry data.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
14
Includes a comparison table of clinical outcomes (ORR/CR) for NXC-201 vs competitors.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
15
Immix Biopharma | Investor Presentation Deck | 46 slidesImmix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
16
The slide compares two disease indications side-by-side with clinical metrics and competitive market context.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
01
jetBlue | Results Presentation Deck | 19 slidesjetBlue | Results Presentation Deck | 19 slides · jetBlue
Conference presentation Investor relations Beat · Attention1 hit
02
jetBlue | Results Presentation Deck | 19 slidesjetBlue | Results Presentation Deck | 19 slides · jetBlue
Conference presentation Investor relations Beat · Interest1 hit
03
jetBlue | Results Presentation Deck | 19 slidesjetBlue | Results Presentation Deck | 19 slides · jetBlue
Conference presentation Investor relations Beat · Interest1 hit
04
jetBlue | Results Presentation Deck | 19 slidesjetBlue | Results Presentation Deck | 19 slides · jetBlue
Conference presentation Investor relations Beat · ComplicationLoop · Cost Of Inaction1 hit
05
The slide uses a causal-chain/before-after-bridge hybrid structure to link specific problems to specific solutions.jetBlue | Results Presentation Deck | 19 slides · jetBlue
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
06
jetBlue | Results Presentation Deck | 19 slidesjetBlue | Results Presentation Deck | 19 slides · jetBlue
Conference presentation Investor relations Beat · WhyLoop · Cost Of Inaction1 hit